Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors not yet approved by the MHRA or EMA for clinical use in the UK
(2018) 10:a029181
WHO GMP-compliant injectable manufacturing facility State-of-the-art lyophilized &
In high-fat diet fed mice, treatment with the triagonist dose-dependently improved steatohepatitis and reduced levels of ALT, underpinning the potential for this compound to treat liver disease (80)
Fast, effective weight management Promotes healthier skin Supports healthy blood pressure and blood sugar levels Helps maintain heart health and overall wellness Strengthens the digestive system Made with natural ingredients, no known side effects Suitable for adults of all ages Supports fat metabolism and liver detoxification No strict diet required, no rebound effect Helps relieve discomfort and swelling Reduces stress and promotes relaxation Boosts energy and vitality Developed and produced in FDA-registered laboratories This is our state-of-the-art laboratory for medical science and technology
Gallbladder Problems: Including gallstones
US$ 21.65
US$ 27.76
US$ 27.66
US$ 21.00
US$ 20.39
US$ 23.65
